ID

24686

Beschreibung

Study ID: 100478 Clinical Study ID: 100478 Study Title: Study to show non-inferiority of Tritanrix™-HepB/Hib-MenAC (+/- hepatitis B vaccine at birth) versus Tritanrix™-HepB/Hiberix™ without hepatitis B vacc. at birth for antibody response to all vaccine antigens given in healthy infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00290303 Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis This form contains the Non-Serious Adverse Events form

Stichworte

Versionen (1)
  1. 13.08.17 13.08.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

13. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

Englisch

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 Formulare  
Non-Serious Adverse Event
Beschreibung

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Beschreibung

non-serious adverse event

Datentyp

boolean

Alias
UMLS CUI [1]
C1518404
AE No.
Beschreibung

AE No.

Datentyp

integer

Alias
UMLS CUI [1]
C0877248
Description:
Beschreibung

Description

Datentyp

text

Alias
UMLS CUI [1]
C0678257
Administration Site
Beschreibung

Administration Site

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0013153
UMLS CUI [1,3]
C0042210
Non-administration site
Beschreibung

Non-administration site

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started:
Beschreibung

Date Started:

Datentyp

date

Alias
UMLS CUI [1]
C0011008
during immediate postvaccination period (30 minutes)
Beschreibung

immediate postvaccination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231291
UMLS CUI [1,2]
C0877248
Date Stopped:
Beschreibung

Date Stopped:

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Maximum Intensity:
Beschreibung

Maximum Intensity:

Datentyp

integer

Alias
UMLS CUI [1]
C0518690
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Beschreibung

Relationship to investigational products:

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome:
Beschreibung

Outcome:

Datentyp

integer

Alias
UMLS CUI [1]
C1705586
Medically attended visit:
Beschreibung

(Refer to protocol for full definition.)

Datentyp

boolean

Alias
UMLS CUI [1]
C0545082
Medically attended visit. If yes please specify type
Beschreibung

Refer to protocol for full definition.

Datentyp

integer

Alias
UMLS CUI [1]
C0545082
Zum Seitenanfang zurückkehren

Ähnliche Modelle

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
non-serious adverse event
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
AE No.
Item
AE No.
integer
C0877248 (UMLS CUI [1])
Description
Item
Description:
text
C0678257 (UMLS CUI [1])
Administration Site
Item
Administration Site
boolean
C1515974 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Non-administration site
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started:
Item
Date Started:
date
C0011008 (UMLS CUI [1])
immediate postvaccination
Item
during immediate postvaccination period (30 minutes)
boolean
C0231291 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Date Stopped:
Item
Date Stopped:
date
C0011008 (UMLS CUI [1])
Item
Maximum Intensity:
integer
C0518690 (UMLS CUI [1])
Maximum Intensity:
Code List
Maximum Intensity:
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Relationship to investigational products:
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome:
integer
C1705586 (UMLS CUI [1])
Outcome:
Code List
Outcome:
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / resolved with sequelae (4)
Medically attended visit:
Item
Medically attended visit:
boolean
C0545082 (UMLS CUI [1])
Item
Medically attended visit. If yes please specify type
integer
C0545082 (UMLS CUI [1])
Medically attended visit:
Code List
Medically attended visit. If yes please specify type
CL Item
Hospitalisation (1)
CL Item
Emergency Room (2)
CL Item
Medical Personnel (3)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video